Stryker Corp. (SYK)
312.10
-5.30
(-1.67%)
USD |
NYSE |
Sep 02, 16:00
314.98
+2.88
(+0.92%)
After-Hours: 20:00
Stryker Research and Development Expense (TTM) : 1.606B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.606B |
| March 31, 2026 | 1.578B |
| December 31, 2025 | 1.567B |
| September 30, 2025 | 1.529B |
| June 30, 2025 | 1.495B |
| March 31, 2025 | 1.451B |
| December 31, 2024 | 1.414B |
| September 30, 2024 | 1.40B |
| June 30, 2024 | 1.371B |
| March 31, 2024 | 1.338B |
| December 31, 2023 | 1.293B |
| September 30, 2023 | 1.249B |
| June 30, 2023 | 1.231B |
| March 31, 2023 | 1.235B |
| December 31, 2022 | 1.23B |
| September 30, 2022 | 1.277B |
| June 30, 2022 | 1.266B |
| March 31, 2022 | 1.253B |
| December 31, 2021 | 1.235B |
| September 30, 2021 | 1.159B |
| June 30, 2021 | 1.095B |
| March 31, 2021 | 1.018B |
| December 31, 2020 | 984.00M |
| September 30, 2020 | 983.00M |
| June 30, 2020 | 987.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.00B |
| December 31, 2019 | 971.00M |
| September 30, 2019 | 938.00M |
| June 30, 2019 | 913.00M |
| March 31, 2019 | 883.00M |
| December 31, 2018 | 862.00M |
| September 30, 2018 | 846.00M |
| June 30, 2018 | 823.00M |
| March 31, 2018 | 799.00M |
| December 31, 2017 | 787.00M |
| September 30, 2017 | 771.00M |
| June 30, 2017 | 757.00M |
| March 31, 2017 | 748.00M |
| December 31, 2016 | 715.00M |
| September 30, 2016 | 690.00M |
| June 30, 2016 | 661.00M |
| March 31, 2016 | 632.00M |
| December 31, 2015 | 625.00M |
| September 30, 2015 | 614.00M |
| June 30, 2015 | 612.00M |
| March 31, 2015 | 616.00M |
| December 31, 2014 | 614.00M |
| September 30, 2014 | 600.00M |
| June 30, 2014 | 583.00M |
| March 31, 2014 | 557.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Intuitive Surgical, Inc. | 1.414B |
| Zimmer Biomet Holdings, Inc. | 442.90M |
| Edwards Lifesciences Corp. | 1.091B |
| Abbott Laboratories | 3.128B |
| Becton, Dickinson & Co. | 1.135B |